Wealth Dimensions Group, Ltd. Astrazeneca PLC Transaction History
Wealth Dimensions Group, Ltd.
- $350 Million
- Q2 2024
A detailed history of Wealth Dimensions Group, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Wealth Dimensions Group, Ltd. holds 5,576 shares of AZN stock, worth $434,537. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,576
Previous 5,613
0.66%
Holding current value
$434,537
Previous $380,000
14.21%
% of portfolio
0.12%
Previous 0.11%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.06 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.32 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.16 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.86 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.37 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...